Hints and tips:
Related Special Reports
...Influencers affiliated with Ogilvy will need to clearly say when they are being paid by a pharma company....
...Its advice to Purdue Pharma on how to boost sales of OxyContin led to claims it contributed to an epidemic of opioid addiction....
...The New York-based pharma group has acquired four companies — Arena, ReViral, Biohaven and Global Blood Therapeutics — that it expects will contribute about $10bn in revenues in 2030....
...The notorious Purdue Pharma case was also selectively filed in a one-judge venue in an apparent attempt to benefit from the presiding judge’s previous rulings in other cases that would allow the Sackler...
...McKinsey has faced repeated claims that its work for Purdue Pharma, the maker of OxyContin, and other drug manufacturers contributed to the US opioid crisis by advising the companies on how to boost sales...
...The Supreme Court on Monday questioned the Department of Justice’s effort to invalidate a settlement in the bankruptcy of Purdue Pharma that would shield members of the company’s founding Sackler family...
...Purdue Pharma, which is owned by the billionaire Sackler family, has been the target of multiple lawsuits and criminal proceedings for promoting the widespread use and safety of the opioids it manufactured...
...The US Supreme Court has put on hold a $6bn bankruptcy settlement by Purdue Pharma that would shield members of the Sackler family that own the company from future lawsuits linked to the US opioids crisis...
...The Supreme Court has put on hold Purdue Pharma’s $6bn bankruptcy settlement that would shield members of the Sackler family who own the company from future lawsuits linked to the US opioid crisis....
...Plaintiffs alleged McKinsey’s advice to clients such as Purdue Pharma, the maker of OxyContin, had directly contributed to the opioid crisis....
...that showed the Sackler family members who own Purdue had taken more than $10bn out of the company between 2008 and 2017....
...Contributions from the company’s acquisitions — notably the $43bn purchase of cancer biotechnology company Seagen — have yet to move the needle....
...US President Joe Biden has put his fight against Big Pharma at the centre of his re-election campaign, championing his efforts to lower drug prices through the Inflation Reduction Act....
...The consultancy has been in the crosshairs of Congress after its marketing work for the opioid maker Purdue Pharma was blamed for contributing to addiction and overdoses, and the data shows that 2023 was...
...for the company)....
...Some members of the dynasty behind Purdue Pharma had secured the releases by putting around $6bn into a settlement with victims....
...Clarifying which companies are responsible for innovations will be “even more important” as pharma companies explore uses for mRNA in cancer, autoimmune diseases and other viruses, said Anna Wolters-Höhne...
...Purdue Pharma, the Sackler-owned company behind the powerful drug OxyContin, tried to use a $6bn bankruptcy settlement to shield members of the family from future lawsuits linked to the US opioid crisis....
...The US’s most controversial bankrupt is Purdue Pharma....
...That may be the subtext from Monday’s Supreme Court oral arguments over the deal struck in the Purdue Pharma bankruptcy....
...But some investors believe selling discipline against a shot is a losing game when big pharma companies are competing to meet the demands of the one in eight people worldwide who are classed as obese....
...OxyContin, a highly addictive drug, was promoted by Purdue Pharma as a non-addictive painkiller in the United States with unimaginably tragic consequences....
...Biotech business Redx Pharma this week blamed low liquidity on London’s junior market for its decision to delist its shares from Aim and re-register as a private company....
...Purdue Pharma, Johnson & Johnson and 3M made deft use of quirks in the US’s Chapter 11 bankruptcy process....
International Edition